Lavelle Erin bought AVLN
April 30, 2026 · Form 4 insider transaction
Lavelle Erin bought 26,978 shares of Avalyn Pharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
26,978
Price
$0.00
Total value
N/A
InsiderLavelle Erin
RoleDirector
CompanyAvalyn Pharma Inc. (AVLN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 30, 2026
Filing dateMay 1, 2026
Shares owned after26,978
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.